| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| RVV08610A |
Human Anti-HCV NS1/gp68/gp70/Envelope glycoprotein E2 (HC33.1) mAb |
100 µg |
$475.00
|
 |
BUY
|
| RVV08610B |
Human Anti-HCV NS1/gp68/gp70/Envelope glycoprotein E2 (HC33.1) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08808A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08808B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08804A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08804B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV04315B |
Human Anti-LASV GPC (37.7F) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV04315A |
Human Anti-LASV GPC (37.7F) mAb |
100 µg |
$475.00
|
|
BUY
|
| CPC542C |
Human Anti-SARS-CoV-2 Spike-RBD (002-S21F2) Broad-Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| VHV22901A |
InVivoMAb Anti-HMPV F/Fusion glycoprotein F0 (MPV467) |
100µg |
$475.00
|
|
BUY
|
| VHV22901B |
InVivoMAb Anti-HMPV F/Fusion glycoprotein F0 (MPV467) |
1mg |
$1,705.00
|
|
BUY
|
| VVV08104A |
InVivoMAb Anti-Nipah virus/NiV F/Fusion glycoprotein F0 Antibody (2D3) |
100 µg |
$475.00
|
|
BUY
|
| VVV08104B |
InVivoMAb Anti-Nipah virus/NiV F/Fusion glycoprotein F0 Antibody (2D3) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VVV08103A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1A9) |
100 µg |
$475.00
|
|
BUY
|
| VVV08103B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1A9) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VVV08102A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1H8) |
100 µg |
$475.00
|
|
BUY
|
| VVV08102B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1H8) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VVV08101B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (4H3) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VVV08101A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (4H3) |
100 µg |
$475.00
|
|
BUY
|
| VVV08106B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (1H1) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VVV08106A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (1H1) |
100 µg |
$475.00
|
|
BUY
|
| VVV08105B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (2B12) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VVV08105A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (2B12) |
100 µg |
$475.00
|
|
BUY
|
| VVV00311A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
100 µg |
$475.00
|
|
BUY
|
| VVV00311B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV00312A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
100 µg |
$475.00
|
|
BUY
|
| VVV00312B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV00315B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00315A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
100 µg |
$475.00
|
|
BUY
|
| VVV00316A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$475.00
|
|
BUY
|
| VVV00316B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$1,715.00
|
|
BUY
|
| VVV00313A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
100 µg |
$475.00
|
|
BUY
|
| VVV00313B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00314B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00314A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
100 µg |
$475.00
|
|
BUY
|
| DVV00332A |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
100 µg |
$475.00
|
|
BUY
|
| DVV00332B |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
1.0 mg |
$1,715.00
|
|
BUY
|
